These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20722625)

  • 1. Co-expression of recombinant human CYP2C9 with human cytochrome P450 reductase in protease deficient S. cerevisiae strain at a higher scale yields an enzyme of higher specific activity.
    Rao KN; Suman SK; Kiran YR; Kuanr AR; Gupta AK; Bhalla K; Kumar V; Kundu P; Arora K; Soni R
    Drug Metab Lett; 2010 Dec; 4(4):246-53. PubMed ID: 20722625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
    Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
    Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
    Locuson CW; Wienkers LC; Jones JP; Tracy TS
    Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.
    Kaspera R; Naraharisetti SB; Evangelista EA; Marciante KD; Psaty BM; Totah RA
    Biochem Pharmacol; 2011 Sep; 82(6):681-91. PubMed ID: 21726541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.
    Crespi CL; Miller VP
    Pharmacogenetics; 1997 Jun; 7(3):203-10. PubMed ID: 9241660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9.
    Boye SL; Kerdpin O; Elliot DJ; Miners JO; Kelly L; McKinnon RA; Bhasker CR; Yoovathaworn K; Birkett DJ
    Xenobiotica; 2004 Jan; 34(1):49-60. PubMed ID: 14742136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4.
    Zhang H; Hamdane D; Im SC; Waskell L
    J Biol Chem; 2008 Feb; 283(9):5217-25. PubMed ID: 18086668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme source effects on CYP2C9 kinetics and inhibition.
    Kumar V; Rock DA; Warren CJ; Tracy TS; Wahlstrom JL
    Drug Metab Dispos; 2006 Nov; 34(11):1903-8. PubMed ID: 16928789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
    Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
    DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
    Emoto C; Iwasaki K
    Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
    Subramanian V; Doddapaneni H; Syed K; Yadav JS
    Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5).
    Im SC; Waskell L
    Arch Biochem Biophys; 2011 Mar; 507(1):144-53. PubMed ID: 21055385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.
    Vail RB; Homann MJ; Hanna I; Zaks A
    J Ind Microbiol Biotechnol; 2005 Feb; 32(2):67-74. PubMed ID: 15739102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae.
    Sakaki T; Shibata M; Yabusaki Y; Murakami H; Ohkawa H
    DNA Cell Biol; 1990 Oct; 9(8):603-14. PubMed ID: 2125425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.